Multi-analyte Controls Unassayed
Clinical Chemistry · 21 CFR 862.1660
A quality control material (unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (unassayed) for blood gases, electrolytes, enzymes, multianalytes, single (specified) analytes, or urinalysis controls.
Recent MDR events
6 adverse event reports on file
- VITROS IMMUNODIAGNOSTIC PRODUCTS HIV COMBO CONTROLS (HIV P24 ANTIGEN)Jun 15, 2022MalfunctionOrtho-clinical Diagnostics3007111389-2022-00060
- VITROS IMMUNODIAGNOSTIC PRODUCTS HIV COMBO CONTROLS (HIV P24 ANTIGEN)May 27, 2022MalfunctionOrtho-clinical Diagnostics3007111389-2022-00051
- LIQUICHEK UNASSAYED CHEMISTRY CONTROL- LEVEL 2Nov 6, 2018MalfunctionBio-rad Laboratories2016706-2018-00005
- LIQUICHEK UNASSAYED CHEMISTRY CONTROL, LEVEL 2Oct 17, 2017MalfunctionBio-rad Laboratories, Inc.2016706-2017-00002
- LIQUICHEK UNASSAYED CHEMISTRY CONTROL, LEVEL 1Oct 16, 2017MalfunctionBio-rad Laboratories, Inc.2016706-2017-00001
- RED CROSS TESTING CHAGAS DISEASE TESTJul 25, 2016InjuryUnkMW5063780
Event type breakdown
Most-reported manufacturers
Recalls
24 recall events for this product code
- TECHNO-PATH MANUFACTURING LTD.Open, ClassifiedNov 14, 2025
Multichem ID-B. Model/Catalog Number: SR103B
Potential of negative recovery of the HBsAg analyte across two (2) lots of Multichem ID-B Positive Control when tested on the Alinity i platform.
Z-0501-2026 · View FDA record ↗ - TECHNO-PATH MANUFACTURING LTD.Open, ClassifiedNov 14, 2025
Multichem ID-B. Model Number: SR103B.
Potential of negative recovery of the HBsAg analyte across two (2) lots of Multichem ID-B Positive Control when tested on the Alinity i platform.
Z-0502-2026 · View FDA record ↗ - Microbiologics IncOpen, ClassifiedMar 25, 2025
Helix Elite Inactivated Standard: Inactivated Influenza A/B and Respiratory Syncytial Virus, Multi-analyte, unassayed quality control material, Catalog Number H
The RSV target may give a late Ct value and could potentially not pass QC.
Z-1454-2025 · View FDA record ↗ - Microbiologics IncOpen, ClassifiedMar 14, 2025
Helix Elite" Inactivated Standard: Inactivated SARS-CoV-2 Whole Virus (Pellet), Multi-analyte, unassayed quality control material, Catalog Number HE0065N
The A549 human cell target (human cells for sample adequacy control) may give a late Ct value.
Z-1371-2025 · View FDA record ↗ - Microbiologics IncOpen, ClassifiedFeb 12, 2025
Microbiologics Multi-Strain Human Papillomavirus (HPV) Control Panel (Inactivated Pellet), REF 8234; in-vitro diagnostic test
Internal quality control procedures were not followed correctly for the testing/release of three lots of 8234/8235. This resulted in the release of products that should have failed and been discarded. The concentration of one target (HPV 16 L1) was low enough to cause QC failures, no detection, or invalid results on some instruments and assays.
Z-1163-2025 · View FDA record ↗ - Microbiologics IncOpen, ClassifiedFeb 12, 2025
Microbiologics Multi-Strain Human Papillomavirus (HPV) Verification Panel (Inactivated Pellet), REF 8235; in-vitro diagnostic test
Internal quality control procedures were not followed correctly for the testing/release of three lots of 8234/8235. This resulted in the release of products that should have failed and been discarded. The concentration of one target (HPV 16 L1) was low enough to cause QC failures, no detection, or invalid results on some instruments and assays.
Z-1164-2025 · View FDA record ↗ - Microbiologics IncOpen, ClassifiedFeb 12, 2024
Microbiologics Enteric Pathogens Control Panel (Inactivated Pellet), REF 8184.
The negative control was contaminated with one of the positive control pathogens (Norovirus). This would result in users getting a positive call for Norovirus when running the negative control.
Z-1075-2024 · View FDA record ↗ - Randox Laboratories Ltd.Open, ClassifiedJan 2, 2024
SEROLOGY ToRCH lgM 2022 POSITIVE CONTROLI Intended for use with in vitro assays for determination of IgM antibodies to Cytomegalovirus (CMV), IgM antibodies to
A decrease in the reactivity of HSV Type 1/2 lgM in the Serology ToRCH lgM Positive Control when tested on the DiaSorin Liaison XL.
Z-0624-2024 · View FDA record ↗ - Biomerieux IncOpen, ClassifiedJan 4, 2023
VIDAS CLINICAL QCV-QUALITY CONTROL VIDAS 60T, CATALOG 30706
As the temperature and time out of range was exceeded, product performances cannot be guaranteed
Z-0800-2023 · View FDA record ↗ - Randox Laboratories Ltd.TerminatedSep 19, 2022
The Randox Serology I Positive Control contains the following analytes in human based plasma: Anti HIV 1/2, Anti HTLV 1/2, Anti HCV, HBsAg, Anti HBc, and Anti T
***Update** :HBsAg analyte is also Non-Reactive on the Ortho Vitros analyser as well as the Beckman Coulter DxI. Randox Serology I Positive Control will test negative (Non-Reactive) for Marker HBsAg resulting in delay in reporting patient results due to the positive control O36SR testing negative (Non-Reactive) for Marker HBsAg
Z-1772-2022 · View FDA record ↗
Registered firms
60 firms currently registered for this product code
Immy, Inc.
NORMAN, OK, US
Randox Laboratories Limited
ANTRIM, COUNTY ANTRIM Antrim and Newtownabbey, GB
Ortho Clinical Diagnostics
Singapore South West, SG
Aesku.diagnostics Gmbh&co.kg
WENDELSHEIM Rhineland-Palatinate, DE
Revvity Discovery Limited
Cambrige Cambridgeshire, GB
Biochemical Diagnostics, Inc.
Edgewood, NY, US
Meridian Bioscience, Inc.
Cincinnati, OH, US
Techno-path Manufacturing Ltd.
Ballina Tipperary, IE
Biomerieux Sa
MARCY L ETOILE Rhone, FR
Mercodia Ab
UPPSALA, SE
Phadia Us Inc.
Portage, MI, US
Ortho-clinical Diagnostics, Inc.
ATHENS, OH, US
Cepheid
Sunnyvale, CA, US
Microgenics Corporation
Fremont, CA, US
Zeptometrix Llc.
Buffalo, NY, US
Meridian Bioscience Canada Inc.
Quebec, CA
Immunostics, Inc.
Eatontown, NJ, US
Sun Diagnostics, Llc
New Gloucester, ME, US
Phadia Ab
UPPSALA, SE
Medtox Diagnostics, Inc.
BURLINGTON, NC, US
Fujirebio Inc.
Sagamihara-shi Kanagawa, JP
Wallac Oy
TURKU Varsinais-Suomi, FI
Dsrv, Inc.
Mount Olive, NJ, US
Cepheid
Lodi, CA, US
510(k) clearances
0 clearances for this product code
No 510(k) clearances on file for this product code.